Correlation Engine 2.0
Clear Search sequence regions

  • A1R (12)
  • adult (1)
  • brain (1)
  • child (1)
  • child preschool (1)
  • fast (5)
  • female (1)
  • human (2)
  • infant (1)
  • interneurons (7)
  • neurons (2)
  • patients (2)
  • pyramidal cells (6)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    This study was to further explore the adenosine dysfunction in refractory epilepsy in Sturge-Weber Syndrome (SWS), to evaluate the neuronal-level effect of the A1 receptor (A1R) agonist on both excitatory pyramidal neurons and inhibitory interneurons, to discuss the possibility of adenosine augmentation therapy (AAT) using A1R agonist for treating refractory epilepsy in SWS. The intrinsic excitatory properties of pyramidal cells (PCs) and fast-spiking (FS) interneurons from human brain tissues with SWS cases and malformations of cortical development (MCD) cases were compared using electrophysiology. With application of either A1R agonist or antagonist, the neuronal-level effect of A1R agonist was evaluated in vitro in PCs and FS interneurons from SWS cases and MCD cases. No significant difference of passive excitatory properties of PCs and FS interneurons was found between SWS cases and MCD cases. In terms of the neuronal-level effect of A1R agonist, with 22.88 ± 1.12% percentage of decreased frequency, FS interneurons showed relatively highest sensitivity of A1R agonist application, compared with PCs from SWS cases and FS interneurons and PCs from MCD cases. Our results supported the potential of AATs using A1R agonist to be a novel therapy for reducing life burden from patients with refractory epilepsy in SWS, with application to epileptic generation region but not propagation region. Copyright © 2020 Elsevier Inc. All rights reserved.


    Xiongfei Wang, Lintian Cao, Yuguang Guan, Quansheng He, Xinghui He, Jian Zhou, Tianfu Li, Guoming Luan. The role of adenosine A1 receptor agonist in adenosine augmentation therapy for patients with refractory epilepsy in Sturge-Weber syndrome: An in vitro electrophysiological study. Epilepsy & behavior : E&B. 2020 May;106:107034

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32208337

    View Full Text